Disruptions in naphtha supplies from the Middle East conflict are driving up costs and forcing production cuts for medical devices across Asia, impacting items like syringes and catheters.

KPMG advises healthcare providers across Asia to treat data as capital, emphasizing investments in governance, interoperability, and analytics to unlock full operational value in hospital management.

A new SmartSense survey indicates that 75% of U.S. hospital CFOs are experiencing increased cost pressures in 2026, with one in four losing over $1M annually to preventable failures, prompting investments in AI for efficiency.

The global Pharma B2B eCommerce market is set to grow from USD 3.47 billion in 2025 to USD 3.90 billion in 2026, driven by digital integration and resilient supply chains for hospital pharmaceuticals procurement.

Two Korean healthtech companies will demonstrate their advanced AI diagnostics and clinical platforms at the WHX Bangkok 2026 event, highlighting Asia's digital transformation in healthcare.

Etiometry announced FDA clearance for its innovative AI solution automating hospital-specific cardiogenic shock classification using real-time physiologic monitoring data.

The Healthcare Asia Summit 2026 begins today in Singapore, spotlighting AI-driven digital transformation to tackle hospital management challenges across Asia.

Restore Robotics has obtained FDA clearance to remanufacture two more da Vinci Xi surgical instruments, expanding its total approvals to four for Intuitive Surgical's systems.

Disruptions in naphtha supplies due to the Strait of Hormuz blockade are driving up costs and forcing production cuts across Asian medical device manufacturers in Japan, South Korea, Singapore, and Indonesia.

Community Health Systems has closed the sale of Crestwood Medical Center as part of its ongoing debt reduction strategy.